Penumbra (PEN) is identified as a solid growth stock by Zacks system

From Nasdaq: 2024-12-25 12:45:03

Investors are seeking growth stocks with above-average financial growth for exceptional returns. However, finding the right growth stock can be challenging due to the associated risks and volatility. Using the Zacks Growth Style Score can help identify cutting-edge growth stocks like Penumbra (PEN), which boasts strong earnings growth, cash flow growth, and promising earnings estimate revisions.

Penumbra (PEN) is a medical device maker recommended by the Zacks system for its favorable Growth Score and top Zacks Rank. With an expected EPS growth of 34.4% this year, well above the industry average, the company also shows impressive cash flow growth of 255.5% year-over-year.

The Zacks system identifies Penumbra as a promising growth stock based on its strong earnings growth, cash flow growth, and positive earnings estimate revisions. With a Zacks Rank #2 and a Growth Score of A, Penumbra is well-positioned for outperformance, making it an attractive option for growth investors.

Zacks is naming the top 10 stocks for 2025, with a history of impressive performance under the direction of Director of Research Sheraz Mian. These handpicked stocks have consistently outperformed the S&P 500, with a track record of significant gains. Stay tuned for the release of the top 10 stocks for 2025 on January 2 for potential investment opportunities.



Read more at Nasdaq: Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think “Yes”